Symbicort Turbuhaler 30/60 Clinical Experience Investigation - SURE
Study identifier:D589IL00001
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Symbicort Turbuhaler 30/60 Clinical Experience Investigation
Medical condition
Bronchial Asthma
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
3643
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Jan 2010
Primary Completion Date: 01 Oct 2011
Study Completion Date: 01 Oct 2011
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2014 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Symbicort Those with an exposure | - |
Contacts
Investigators
Principal Investigator
Yoshida Shigeru
AstraZeneca K.K.
